Mithra Announces Donesta® Phase III Clinical Program Update

Liege, Belgium, 01 April 2020 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces an update on the Donesta® Phase III Clinical Program called “E4 Comfort”, which aims at enrolling approximately 2200 menopausal women (40-65 years) and includes two pivotal studies: in North America (United States/Canada) launched in October 2019, and in Europe, Russia and South America launched in December 2019. For each pivotal study, women will be recruited in about 120 sites in the concerned areas.